Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 8:14:1237506.
doi: 10.3389/fimmu.2023.1237506. eCollection 2023.

Editorial: Delivering nucleic acids to immune and non-immune cells

Kirill A Afonin  1 , Francesca Re  2 , Diana Boraschi  3   4   5
Affiliations
Editorial

Editorial: Delivering nucleic acids to immune and non-immune cells

Kirill A Afonin et al. Front Immunol. .
No abstract available

Keywords: NANPs; antigen presentation; delivery; nanoparticles; nucleic acids; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Delivering nucleic acids to immune and non-immune cells

References

    1. Tseng HF, Ackerson BK, Luo Y, Sy LS, Talarico CA, Tian Y, et al. . Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nat Med (2022) 28(5):1063–71. doi: 10.1038/s41591-022-01753-y - DOI - PMC - PubMed
    1. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. . An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med (2020) 383(20):1920–31. doi: 10.1056/NEJMoa2022483 - DOI - PMC - PubMed
    1. Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, et al. . The current landscape of nucleic acid therapeutics. Nat Nanotechnol (2021) 16(6):630–43. doi: 10.1038/s41565-021-00898-0 - DOI - PubMed
    1. Johnson MB, Chandler M, Afonin KA. Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects. Adv Drug Deliver Rev (2021) 173:427–38. doi: 10.1016/j.addr.2021.04.011 - DOI - PMC - PubMed
    1. Afonin KA, Dobrovolskaia MA, Church G, Bathe M. Opportunities, barriers, and a strategy for overcoming translational challenges to therapeutic nucleic acid nanotechnology. ACS Nano (2020) 14(8):9221–7. doi: 10.1021/acsnano.0c04753 - DOI - PMC - PubMed

Publication types

LinkOut - more resources